Business
Bio Spectrum
Empowered By Innovation
We are setting up Med Tech Accelerator within our existing state of art campus.
4 min |
July 2017
Bio Spectrum
Invest In It Backbone And Interoperability Standards In Healthcare
Digital technologies can help both private and public sector’s program leaders to improve service delivery for all and the digital health programmes would have much deeper impact for rural masses
4 min |
July 2017
Bio Spectrum
The Policy Is A Game Changer
Recently, JP Nadda, Union Minister for Health and Family Affairs, released the National Health Policy (NHP) 2017. Patting the back of the minister, Prime Minister Narendra Modi described the policy as a ‘futuristic’ document which places the interests of the citizens foremost.
4 min |
April 2017
Bio Spectrum
Policy Covers NCD Concerns
The National Health Policy 2017 covers various aspects like care for major non-communicable diseases (NCDs), geriatric healthcare, mental health, palliative care and rehabilitative care services.
5 min |
April 2017
Bio Spectrum
The Generic Drug Push Needs Further Clarity
The policy encourages indigenous production of APIs and Key Starting Materials (KSMs) in several ways. However, a more thorough approach is required to once again enable the domestic API industry to become competitive. The Indian government needs to focus on developing the local chemical industry which can then in turn support API manufacturing.
4 min |
October 2017
Bio Spectrum
Aims At Providing A Longer Term Stable Policy Environment
To overcome the challenges like Declining CAGR; Non-adherence to quality standards and norms; Growing competition from other countries; Dependence on imports for the key starting materials as also of the APIs; Lack of R&D and discovery of new molecules, and to improve the situation of the pharma industry, India has come up with draft pharma policy 2017.
5 min |
October 2017
Bio Spectrum
Amgen Collaborates With Humana To Improve Health Outcomes
US Biotechnology company, Amgen and leading health organization, Humana have teamed up to identify opportunities to improve health outcomes and improve efficiency by unlocking new insights from the real world health care experiences of Humana's 13 million members.
1 min |
October 2017
Bio Spectrum
Rich Agricultural Base To Boost State's Biotech Sector
Punjab, one of the prominent agricultural states of the country, is now shifting its gears from just being an agricultural state to biotechnology hub of North India.
2 min |
February 2017
Bio Spectrum
Can State Make Biotech Park A Reality?
Governments worldwide have recognised biotech as a new age technology that is anticipated to play a significant role in improving the quality of life, at large.
2 min |
February 2017
Bio Spectrum
“The Field Of Healthcare Is Changing Big Time Now”
“The Field Of Healthcare Is Changing Big Time Now”
3 min |
January 2018
Bio Spectrum
Over 1500 Exhibitors From 40 Countries Showcase Their Products
Over 1500 Exhibitors From 40 Countries Showcase Their Products
4 min |
January 2018
Bio Spectrum
With Proper Government Support India Can Rule Medical Device Sector
With Proper Government Support India Can Rule Medical Device Sector
5 min |
January 2018
Bio Spectrum
NB Ventures Invest Into Mobiefit
NB Ventures Invest Into Mobiefit
1 min |
January 2018
Bio Spectrum
Cadila Pharma Receives Healthcare Leadership Award
Cadila Pharma Receives Healthcare Leadership Award
1 min |
January 2018
Bio Spectrum
Merck To Set Up Research Facility In London
Merck To Set Up Research Facility In London
1 min |
January 2018
Bio Spectrum
Clermont Invests Rs 155cr In Indiabulls Pharma
Clermont Invests Rs 155cr In Indiabulls Pharma
1 min |
January 2018
Bio Spectrum
Temasek Acquires Rs 1000 Cr Stake In Manipal Hospitals
Singapore’s Temasek Holding has agreed to acquire a Rs 1,000-crore stake in Manipal Hospitals in a deal that possibly turns the Bengaluru-based private healthcare network into an industry consolidator.
1 min |
November 2017
Bio Spectrum
Analytica ANACON India And India Lab Expo 2017
259 exhibitors showcase products
3 min |
November 2017
Bio Spectrum
China's Maiden Billion-Dollar Takeover Of An Indian Pharma Giant
The deal will help the Chinese company make inroads into India, gain access to US injectable drug market where Gland has a firm hold and bolster its product portfolio.
6 min |
November 2017
Bio Spectrum
People News
Veteran Biologist And Activist Passes Away.
1 min |
September 2017
Bio Spectrum
Scientists Took To Streets For Robust Funds
Thousands of scientists, students, educational NGOs and science enthusiasts across the country came out on the streets on August 9th demanding robust funding for scientific research and policies to encourage a scientific temper among the population.
4 min |
September 2017
Bio Spectrum
​“In India Till Now, Bioresearch Is Considered To Be A Bit Costly”
Dr Ashes Ganguly, founder Director of Cryogen Instruments India, one of the leading suppliers of Speciality/Isotopic Gases and Nuclear Medicines in the country, is heading the Indian Analytical Instrument Association (IAIA) as president since 2015 till 2018. In an interaction with BioSpectrum he shares his views as President of IAIA on government’s Make in India scheme and GST etc. Experts of the interview.
3 min |
September 2017
Bio Spectrum
“Devise Simple Health Insurance Products To Enhance Coverage”
FICCI HEALTH INSURANCE CONFERENCE 2017
2 min |
February 2018 ,Vol 16 Issue 05
Bio Spectrum
Batavia Joins International Consortium For Polio Eradication
Netherlands based Batavia Biosciences is joining an international consortium to develop and manufacture a safer type of polio vaccine.
1 min |
February 2018 ,Vol 16 Issue 05
Bio Spectrum
Shortage In Europe Of Oncology Drugs... An Opportunity For Indian Pharma?
Indian drug companies are facing strong headwinds due to prompt regulatory action of United States Food and Drug Administration (USFDA), likely imposition of Border Adjustment Tax (BAT) and delay in new drug approvals. Probably, it is the best time for Indian pharma companies to explore opportunities and business in the European market.
8 min |
August 2017
Bio Spectrum
US FDA Warning Letters And Indian Pharma
Greater emphasis on quality will allow India to participate more fully in existing global venues such as the International Council for Harmonisation (ICH) and the Pharmaceutical Inspection Cooperation Scheme (PIC/S) – which will enable stronger collaboration and synergies among regulators. Quality is good for economic development, the market, and most importantly, patients and consumers everywhere.
9 min |
August 2017
Bio Spectrum
Industry Needs To Work Closely With Indian Govt For Smooth Implementation Of GST
The new tax regime will contribute significantly towards every sector of economic growth, broad export expansion and without saying ample job opportunities. GST is collaborative approach and much awaited tax reform and it is a one more welcome step to move ahead towards more globalization. The roll out will yield many positive benefits but Companies will need to make major changes in their process.
7 min |
August 2017
Bio Spectrum
The Future of Biotechnology in India
Dr Harsh Vardhan, Minister, Union Minister, Science and Technology, Earth Science, shares with BioSpecturm the prospects and plans for the biotechnology and medical technology sectors.
7 min |
November 2016
Bio Spectrum
Inclusive Healthcare for Digital India?
Inclusive Healthcare for Digital India?
4 min |
November 2016
Bio Spectrum
Karnataka To Work On Health Technologies
Policy and Regulatory News
1 min |